Trial intelligence / Profile preview

Citrate pharmacokinetics in acute liver failure patients receiving continuous renal replacement therapy

TCTR20210707010Phase 3Completed

Sponsor
Excellence Center for Critical Care Nephrology
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trisodium citrate in fulminant hepatitis, sponsored by Excellence Center for Critical Care Nephrology. Started Jul 2019; status: completed.

02

Drugs

trisodium citrate
03

Conditions

fulminant hepatitis

Beyond the preview

Go deeper on TCTR20210707010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210707010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call